A journey of desperation and elation - Trying to change outcomes in childhood brain cancer
Tracks
Track 1
Track 2
Track 3
Track 4
| Friday, October 23, 2026 |
| 9:30 AM - 10:10 AM |
| Plenary / Clinical Innovation & Patient Impact Breakout Room |
Details
A very personal and candid experience of a thirteen year journey to improve outcomes for pediatric brain cancer. Including two case reports involving a high grade glioma with leptomeningeal disease, and a progressive medulloblastoma case. A synopsis of the PeadNeoVax trial, and a few thoughts on what lies ahead for cancer immunotherapy in general.
Speaker
Dr Robyn Lindner
Director of State & Committee Engagement
AusBiotech Ltd
Chair
Mr Brad Sorenson
Founder and CEO
Providence Therapeutics
Keynote
